Association analysis of dopaminergic gene variants (COMT, DRD4 and DAT1) with Alzheimer's disease

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 3, 2012, Pages 401-410

  Lin, W Y ^a,b   Wu, B T ^a   Lee, C C ^b,c   Sheu, J J ^a,b   Liu, W F ^d   Wang, W F ^e   Tsai, C H ^a,b   Liu, Hsin Ping ^a   Tsai, Fuu Jen ^a,b,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Alzheimer's disease; Dopamine; Neurotransmitter; Polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 4 RECEPTOR;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DAT1 GENE; DOPAMINERGIC TRANSMISSION; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CATECHOL O-METHYLTRANSFERASE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D4; TAIWAN;

EID: 84868114564     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA 1988; 85(11):4051-5.
2. Sivaprakasam K. Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation. Curr Med Chem 2006; 13(18):2179-88. (Pubitemid 44132608)
3. Parameshwaran K, Dhanasekaran M, Suppiramaniam V. Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol 2008; 210(1):7-13. (Pubitemid 351258072)
4. Parameshwaran K, Sims C, Kanju P, Vaithianathan T, Shonesy BC, Dhanasekaran M, et al. Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function. Synapse 2007; 61(6):367-74. (Pubitemid 46559534)
5. Venkitaramani DV, Chin J, Netzer WJ, et al. Beta-amyloid modulation of synaptic transmission and plasticity. J Neurosci 2007; 27(44):11832-7. (Pubitemid 350072092)
6. Harkany T, Abraham I, Timmerman W, et al. beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci 2000; 12(8):2735-45.
7. Walsh DM, Klyubin I, Fadeeva JV, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416(6880):535-9. (Pubitemid 34288854)
8. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009;62(6):788-801.
9. Walsh DM, Klyubin I, Fadeeva JY, Rowan MJ, Selkoe DJ. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 2002; 30(4):552-7. (Pubitemid 35001597)
10. Gao C, Sun X, Wolf ME. Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons. J Neurochem 2006; 98(5):1664-77. (Pubitemid 44200455)
11. Mockett BG, Guevremont D, Williams JM, Abraham WC. Dopamine D1/D5 receptor activation reverses NMDA receptor-dependent long-term depression in rat hippocampus. J Neurosci 2007; 27(11):2918-26. (Pubitemid 46438973)
12. Jurgensen S, Antonio LL, Mussi GE, et al. Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers. J Biol Chem 2011; 286(5):3270-6.
13. Ji Y, Olson J, Zhang J, Hildebrandt M, et al. Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer research 2008; 68(14):5997-6005.
14. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6(3):243-50. (Pubitemid 26226317)
15. Chen CY, Lu RB, Yeh YW, Shih MC, Huang SY. Association study of catechol-O-methyltransferase gene polymorphisms with schizophrenia and psychopathological symptoms in Han Chinese. Genes, brain, and behavior 2011; 10(3):316-24.
16. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73(5):1162-9. (Pubitemid 37414228)
17. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375(6534):754-60.
18. Steiner H, Romig H, Grim MG, et al. The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing. J Biol Chem 1999; 274(12):7615-8.
19. Kim JH, Anwyl R, Suh YH, Djamgoz MB, Rowan MJ. Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J Neurosci 2001; 21(4):1327-33. (Pubitemid 32128777)
20. Yoshiyama Y, Higuchi M, Zhang B, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007; 53(3):337-51. (Pubitemid 46161268)
21. Navakkode S, Sajikumar S, Frey JU. Synergistic requirements for the induction of dopaminergic D1/D5-receptor-mediated LTP in hippocampal slices of rat CA1 in vitro. Neuropharmacology 2007; 52(7):1547-54. (Pubitemid 46678088)
22. White NM, Packard MG, Seamans J. Memory enhancement by post-training peripheral administration of low doses of dopamine agonists: possible autoreceptor effect. Behav Neural Biol 1993; 59(3):230-41. (Pubitemid 23184478)
23. Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999; 51(4):593-628.
24. Vandenbergh DJ, Persico AM, Hawkins AL, et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14(4):1104-6. (Pubitemid 23053054)
25. Fischer P, Simanyi M, Danielczyk W. Depression in dementia of the Alzheimer type and in multi-infarct dementia. Am J Psychiatry 1990; 147(11):1484-7. (Pubitemid 20365437)
26. Sweet RA, Devlin B, Pollock BG, et al. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease. Molecular psychiatry 2005; 10(11):1026-36. (Pubitemid 41541988)
27. Glatt SJ, Faraone SV, Tsuang MT. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 2003; 160(3):469-76. (Pubitemid 41094254)
28. Grunblatt E, Zehetmayer S, Bartl J, et al. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study. J Psychiatr Res 2009; 43(3):298-308.
29. Nicholl DJ, Bennett P, Hiller L, et al. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology 1999; 53(7):1415-21. (Pubitemid 29491930)
30. Cordeiro Q, Siqueira-Roberto J, Vallada H. Association between the SLC6A3 A1343G polymorphism and schizophrenia. Arq Neuropsiquiatr 2010; 68(5):716-9.